Rehabilitation Program as an Alternative Therapy for Moderate to Severe Obstructive Sleep Apnea Syndrome (Rehsolvas)
Primary Purpose
Sleep Apnea, Obstructive, Metabolic Syndrome
Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
In-patient rehabilitation
Educational activities alone
Sponsored by
About this trial
This is an interventional treatment trial for Sleep Apnea, Obstructive focused on measuring Obstructive Sleep Apnea/Hypopnea Syndrome, Exercise training program, Inflammation, Oxidative Stress, Resistance to insulin
Eligibility Criteria
Inclusion Criteria:
- Moderate to severe Obstructive Sleep Apnea Hypopnea Syndrome (AHI > 15/h)
- Sedentary patient (Activity Voorrips Questionnary score < 9,4)
Exclusion Criteria:
- OSAS already treated by CPAP or other therapy (OAM,...)
- BMI > 40/m²
- Hypnotic and sedative medications
- Cranio-facial malformation
- Obstructive respiratory disease (COPD, asthma,...)
- Instable heart ischemic disease and all
Sites / Locations
- Clinique du souffle "La Solane"
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
In-Patient Rehabilitation
Educational activities alone
Arm Description
Sessions of rehabilitation contains : Individualized exercise training Educational activities Dietary advices
Out-patient control arm contains only : -Educational activities
Outcomes
Primary Outcome Measures
Delta of the Apnea/Hypopnea Index (AHI)between the two arms
Comparing Delta of AHI 4 weeks (J0/J28) after starting the intervention (assessed by polysomnography at inclusion - end monitoring) between the two arms using the Student t test or Wilcoxon test if the distribution is not Gaussian.
Secondary Outcome Measures
Full Information
NCT ID
NCT01362777
First Posted
May 26, 2011
Last Updated
September 19, 2011
Sponsor
5 Santé
Collaborators
A.E.R.O.B.I.E., INSERM U1046 Physiologie et médecine expérimentale du cœur et des muscles
1. Study Identification
Unique Protocol Identification Number
NCT01362777
Brief Title
Rehabilitation Program as an Alternative Therapy for Moderate to Severe Obstructive Sleep Apnea Syndrome
Acronym
Rehsolvas
Official Title
Effects of an In-Patient Individualized Rehabilitation Program on Severity and Symptoms of Obstructive Sleep Apnea Syndrome (OSAS):Results of a Randomized Controlled Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
September 2011
Overall Recruitment Status
Completed
Study Start Date
November 2007 (undefined)
Primary Completion Date
June 2010 (Actual)
Study Completion Date
August 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
5 Santé
Collaborators
A.E.R.O.B.I.E., INSERM U1046 Physiologie et médecine expérimentale du cœur et des muscles
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The obstructive sleep apnea/hypopnea syndrome (OSAS) is a common disease (2-4% of the general population) that generates intermittent hypoxemia and sleep fragmentation. OSAS is associated with various metabolic disorders such as metabolic syndrome, type 2 diabetes. OSAS is a risk factor for cardio-vascular diseases by increasing morbidity/mortality. OSAS patients suffer from excessive daytime sleepiness (EDS), a symptom also responsible for at least 30% of traffic accidents but also other cognitive disorders with significant impact on quality of life. OSAS generates oxidative stress, inflammation and resistance to insulin and other systemic metabolic dysregulation of many whose levels are correlated with the severity of the disease.
Treatment with Continuous Positive Airway Pressure (CPAP) has clearly demonstrated its effectiveness to eliminate apneas and improve EDS but it is sometimes difficult to accept and/or poorly tolerated, limiting its effectiveness.
Weight loss and regular physical activity are clearly recommended but rarely done in clinical practice. A few studies have applied to study the effects of rehabilitation training (REE) on the sleep apnea patients and have shown an improvement in sleep quality, reduction of awakenings and arousals from sleep and the Index of Apnea/Hypopnea (AHI), but their methodology was questionable, and the number of patients included was too low.
The investigators hypothesis is that an in-patient multidisciplinary rehabilitation program comprising educational activities, dietary management and individualized exercise training (IET) will decrease OSAS severity, improve sleep quality and symptoms (EDS, fatigue, QoL). This IET program (24 sessions during 4 weeks) could also help to improve many metabolic dysregulation, inflammation and oxidative stress (also markers of cardiovascular risk). Leptin, a hormone involved in regulating appetite, energy expenditure and ventilatory control is increased in OSA (mechanism of leptin resistance). The improved sensitivity to leptin may play a role in enabling a better control of ventilation in these patients.
Detailed Description
The obstructive sleep apnea/hypopnea syndrome (OSAS), with an estimated prevalence of between 2 and 4% (1) is characterized by repetitive obstructions of the upper airway that generate intermittent hypoxemia and sleep fragmentation. The typical clinical profile of the apneic patient is an middle aged (50-55 years) obese male, snoring and drowsy. Moreover, OSAS is a risk factor for hypertension independent of obesity (2, 3) and it is now clear evidence that untreated apnea patients have high cardiovascular morbidity / mortality (CVM) higher than subjects treated with CPAP (4-6).
Clinically, excessive daytime sleepiness (EDS) is the main symptom (7) but the attentional and cognitive disorders (8.9), depression or simply a state of fatigue are other possible manifestations of OSAS. The impact on quality of life (QoL) (10-12) are significant and underestimated. The origins of this drowsiness are multiple: one finds the fragmentation of sleep (13,14), intermittent hypoxia, respiratory effort, obesity (15) and certain cytokines such as TNF-alpha and IL-6 involved in sleep regulation (16-19).
On the pathophysiology, the investigators find in the obstructive apneic oxidative stress (20-24) and systemic inflammation (25-27). CRP and levels of some cytokines (IL-1 beta, IL-6, IL-8 and TNF-alpha) are increased and their levels are correlated with the severity of disease as the increase of CVD (28-30 ). Intermittent hypoxia appears to play an essential role in the genesis of these abnormalities (31).
On the metabolic dysregulation of many coexist. Found abnormal fasting blood glucose, a state of insulin resistance, dyslipidemia, and hyperleptinemia. Insulin resistance increases with body weight independent of the index of apnea / hypopnea (AHI) (18, 32-34). Intermittent hypoxia appears to be the cause. Leptin secreted by adipocytes, regulates weight by controlling appetite and energy expenditure. The hyperleptinemia found in OSA is controversial. Obesity appears to be primarily responsible for some (36) while others suggest the role of nocturnal hypoxemia (37). In fact, it is more the state of leptin resistance that hyperleptinemia alone that seems to be involved.
Treatment with continuous positive airway pressure (CPAP) has clearly demonstrated its effectiveness to suppress apneas and sleep fragmentation associated. A meta-analysis (38) has confirmed the improvement of IDS by the PPC. However, in less severe forms, improving the SDE is less clear (39) and the PPC is sometimes not easily accepted, not tolerated and limiting its effectiveness is its poor compliance (40,41). From a pathophysiological point of view, CSF improves systemic inflammation (26,27) and diminishes the CVD (5.6). For cons, the metabolic dysregulation (insulin resistance, hyperleptinemia, dyslipidemia) are improving somewhat CPAP except in patients without obesity (42-44).
The dietary guidelines are essential for the management of this disease is the result for a large part of a healthy lifestyle deleterious. Weight loss, regular physical activity is also clearly recommended but unfortunately rarely performed and / or supported by our healthcare system. Few studies have focused on studying the effects of such treatment on sleep apneic patients. In normal subjects, the effects of exercise on sleep are described in a meta-analysis (45). The practice of regular physical activity endurance improves quality of sleep (45-47). Sleep latency is shorter, there is less change in stages and fewer awakenings and arousals from sleep. Unlike other studies show that in situations where physical activity is reduced (physical inactivity, obesity, or prolonged bed rest, for example) sleep deteriorates, breaks and daytime alertness decreases. The effect of exercise in OSAS (48,49) and especially the training in physical exercise (48) shows an improvement in sleep quality and reduction of awakenings and arousals from sleep and fewer respiratory events (IAH). Pathophysiological point of view, there is a decrease in concentrations of leptin (50-53) and inflammatory cytokines (54-55) in different populations of subjects (healthy, older, obese, or with heart failure). And the investigators know the effects of exercise on carbohydrate metabolism in particular (decreased insulin resistance).
And physical activity improves sleep quality in normal subjects while in parallel it would have an anti-inflammatory. For patients with severe OSAS, our hypothesis is to improve the quality of sleep (SLP rate) and a decrease in AHI and EDS through rehabilitation training (REE) associated with a comprehensive care (patient education, dietary, psychological, ...). On the pathophysiology, this improvement would be through a reduction of biological abnormalities associated with OSA are also markers of cardiovascular risk. Mainly metabolic disorders, oxidative stress and systemic inflammation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea, Obstructive, Metabolic Syndrome
Keywords
Obstructive Sleep Apnea/Hypopnea Syndrome, Exercise training program, Inflammation, Oxidative Stress, Resistance to insulin
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
26 (Actual)
8. Arms, Groups, and Interventions
Arm Title
In-Patient Rehabilitation
Arm Type
Experimental
Arm Description
Sessions of rehabilitation contains :
Individualized exercise training
Educational activities
Dietary advices
Arm Title
Educational activities alone
Arm Type
Active Comparator
Arm Description
Out-patient control arm contains only :
-Educational activities
Intervention Type
Behavioral
Intervention Name(s)
In-patient rehabilitation
Other Intervention Name(s)
Individualized exercise training, Educational activities, Dietary management
Intervention Description
Individualized exercise training (IET):
Duration : 24 sessions during 4 weeks
IET session (2h) contains:
15' start warming up muscles
30' muscle strengthening exercise for arms and abdominal muscles
45' individualized cycle ergometer endurance training to the ventilatory threshold heart rate measured on the cardiopulmonary exercise test.
15' stretching
15' postural, movement and balance exercises IET session was controlled by a professional instructor using heart rate monitoring. Duration, intensity and attendance were recorded in a logbook.
Educational activities (20h): the 8 themes are comparable to comparator arm. Dietary management: was performed by dietician to ensure that energy intakes are adjusted to energy expenditure. No restrictive diet was prescribe.
Intervention Type
Behavioral
Intervention Name(s)
Educational activities alone
Other Intervention Name(s)
Educational activities
Intervention Description
Educational activities alone contains 10 sessions lasting 1:00 with 8 themes :
Physiological mechanisms of apneas/hypopneas
Effects of apneas/hypopneas on health (vascular morbidity/mortality and sleepiness)
Beneficials effects of CPAP and/or advanced mandibular orthosis
Description of sleep stages and physiological roles of sleep
Known effects of exercise on sleep and metabolism
Importance of good nutritional status and sleep hygiene on quality of life
How to apply theses lessons of rehabilitation in daily life
Primary Outcome Measure Information:
Title
Delta of the Apnea/Hypopnea Index (AHI)between the two arms
Description
Comparing Delta of AHI 4 weeks (J0/J28) after starting the intervention (assessed by polysomnography at inclusion - end monitoring) between the two arms using the Student t test or Wilcoxon test if the distribution is not Gaussian.
Time Frame
participants will be followed for the duration of hospital stay, an expected average of 4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Moderate to severe Obstructive Sleep Apnea Hypopnea Syndrome (AHI > 15/h)
Sedentary patient (Activity Voorrips Questionnary score < 9,4)
Exclusion Criteria:
OSAS already treated by CPAP or other therapy (OAM,...)
BMI > 40/m²
Hypnotic and sedative medications
Cranio-facial malformation
Obstructive respiratory disease (COPD, asthma,...)
Instable heart ischemic disease and all
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthieu DESPLAN, MD
Organizational Affiliation
CHU Montpellier, INSERM U1046
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinique du souffle "La Solane"
City
Osseja
ZIP/Postal Code
66340
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
24947878
Citation
Desplan M, Mercier J, Sabate M, Ninot G, Prefaut C, Dauvilliers Y. A comprehensive rehabilitation program improves disease severity in patients with obstructive sleep apnea syndrome: a pilot randomized controlled study. Sleep Med. 2014 Aug;15(8):906-12. doi: 10.1016/j.sleep.2013.09.023. Epub 2014 Apr 1.
Results Reference
derived
Learn more about this trial
Rehabilitation Program as an Alternative Therapy for Moderate to Severe Obstructive Sleep Apnea Syndrome
We'll reach out to this number within 24 hrs